RecruitingNCT03273049

Mapping Disease Pathways for Biliary Atresia

Coordinating Center- Mapping Disease Pathways for Biliary Atresia


Sponsor

University of Pittsburgh

Enrollment

1,100 participants

Start Date

Jul 21, 2016

Study Type

OBSERVATIONAL

Conditions

Summary

This project will primarily evaluate the developmental/genetic basis of biliary atresia, the most common cause of liver failure at birth, and which accounts of half of all liver transplants performed worldwide in children.


Eligibility

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with biliary atresia. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

UPMC Children's Hospital of Pittsburgh

Pittsburgh, Pennsylvania, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03273049


Related Trials